Tag Archives: Accelerating Detection of Disease (ADD) Challenge

Dementia Moonshot Report: Research Priorities and Costs (Alzheimer’s Research UK)

Posted on January 25, 2020 by Dementia and Elderly Care News

Summary Alzheimer’s Research UK (ARUK) have released a brief report on six research priorities, which are: Achieving earlier detection of diseases which may cause dementia, (ideally by 10-15 years), to enhance development of new treatments / interventions for people most … Continue reading →

Posted in Alzheimer’s Research UK, Charitable Bodies, Commissioning, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, Models of Dementia Care, National, Non-Pharmacological Treatments, Pharmacological Treatments, Quick Insights, UK, Universal Interest | Tagged Accelerating Alzheimer's Research and Drug Development, Accelerating Detection of Disease, Accelerating Detection of Disease (ADD) Challenge, Accelerating Detection of Disease Programme, Alzheimer's and Dementia: Translational Research and Clinical Interventions (TRCI), Alzheimer’s Research UK (ARUK), Alzheimer’s Research UK’s Dementia Attitudes Monitor, Alzheimer’s Research UK’s Drug Discovery Alliance, Awareness, Awareness Raising, Benefits of Detection and Early Intervention, Benefits of Early Detection, Biomarker Development, Biomarkers, Brain Health Clinics, Charity Research Support Fund, Cognitive Function and Ageing Study II, Cross-Funder Review, Dementia Access Taskforce, Dementia Consortium, Dementia Moonshot, Dementia Prevalence, Dementia Prevention, Dementia Research, Dementia Research and Drug Development, Dementia Research Funding, Dementia Research Priorities, Dementia Risk Reduction, Dementia Risk Reduction and Prevention, Dementia Translational Medicines Accelerator, Dementia: Prevalence and Detection, Dementias Platform UK, DPUK: Dementias Platform UK, Dr Helen Beaumont: Alzheimer’s Research UK Champion, Drug Development for Alzheimer's Disease, Drug Discovery Alliance, Drug Discovery Institutes, Drug Target Validation, Early Detection of Neurodegenerative Diseases, Economic Impact of Dementia, Global Impact of Dementia, Global Leadership, Government Research Funding, Grand Challenge on Artificial Intelligence and Data, Helen Stokes-Lampard: Chair of RCGP, Hilary Evans: Chief Executive of Alzheimer’s Research UK, Impact of Dementia, Impact of Dementia (Statistics), Impact of Dementia in UK, Life Sciences Industrial Strategy, Life-Changing Treatment for Dementia by 2025 (Moonshot Aim), Medical Research Charities, Mike Gooley Trailfinders Charity Prevention and Risk Reduction Fund, Modifiable Risk Factors, Multi-Morbidities, Multi-Morbidity, No Time to Lose: An Action Plan for Dementia (ARUK), Participation in Research, Patient Involvement in Research, Potential Drug Targets, Preclinical Biomarkers and Dementia, Preclinical Biomarkers in Alzheimer's Disease, Professor Jamie Waterall: National Lead for Cardiovascular Disease at Public Health England, Professor Tara Spires-Jones: Alzheimer’s Research UK Grant Review Board, Research Funding, Research Priorities and Funding / Costs, Research Priorities and Networks, Social and Economic Impact of Dementia, Social and Economic Impact of Dementia in UK, Target Robustness Programme, Translational Medicines, Translational Research, UK Dementia Research Institute, UK Dementia Research Institute (UK DRI), UK Health Research Funding | Leave a comment

Advancing Population Health: Government Consulation on Personalised Medicine and Prevention for the 2020s (BBC News / Cabinet Office / DHSC)

Posted on July 28, 2019 by Dementia and Elderly Care News

Summary It is expected that, by the 2020s, technological advances including genomics and artificial intelligence (AI) will massively improve “proactive, predictive, and personalised” approaches to the prevention of ill health. A wide-ranging consultation document explains many of the options, opportunities … Continue reading →

Posted in Assistive Technology, BBC News, Commissioning, Community Care, Department of Health, Department of Health and Social Care (DHSC), Depression, Diagnosis, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), In the News, Integrated Care, Management of Condition, Mental Health, National, NHS, Non-Pharmacological Treatments, Parkinson's Disease, Person-Centred Care, Personalisation, Public Health England, Quick Insights, Standards, UK, Universal Interest | Tagged Accelerating Detection of Disease (ADD) Challenge, Accelerating Detection of Disease Programme, Accelerating Detection of Disease Projects, Active Ageing, Active Lifestyle, Active Play, Active Travel, Adapting Homes and Neighbourhoods, Adult Social Care: £7.5 Million for Research to Improve Care Delivery, Advanced Pain Discovery Platform, Advanced Pain Discovery Platform: Mapping the Complexity of Chronic Pain, Advancing Our Health: Prevention in the 2020s (DHSC 2019 Consultation), Advancing our Health: Prevention in the 2020s (Green Paper), Age-Friendly Environments, Ageing Population, Ageing Society, Ageing Society Grand Challenge, Air Quality Expert Group (AQEG), Alcohol Abuse, Alcohol Care Teams, Alcohol Misuse, Anti-Smoking Legislation, Anxiety, Asset-Based Approaches, Asset-Based Approaches to Health and Wellbeing, Baroness Blackwood, BBC Devon News, Biotechnology and Biological Science Research Council (BBSRC), Broad Determinants of Health, Cabinet Office, Centres of Excellence in Digital Pathology and Imaging, Changing Behaviours in Public Health, Changing Places Toilets, Childhood Obesity Strategy, Childhood Obesity Strategy (Chapter 3), Children’s Oral Health, Cigarette Smoking, Clean Air Strategy, Committee on the Medical Effects of Air Pollutants (COMEAP), Community Pharmacies, Composite Health Index, Comprehensive Model for Personalised Care, Connected Society: Strategy for Tackling Loneliness (2018), Consensus Statement on Healthy Ageing : PHE and the Centre for Ageing Better, Consultation, Coventry, Cycling and Walking Investment Strategy, Cystic Fibrosis, Cystic Fibrosis Trust, Dementia-Friendly Communities, Dementia-Friendly Neighbourhoods, Department for Business Energy and Industrial Strategy (BEIS), Depression, Diabetes Prevention Programme, Diagnostic Technology, Diagnostic Tests Involving AI, Disability-Friendly Environments, Drivers of Good Health, Drug or Alcohol Misuse, Early Diagnosis and Treatment of Chronic Diseases, Early Screening, Elexacaftor, Embedding Scientific and Technological Developments: Genomics Robotics and Artificial Intelligence (AI), Energy Performance Certificate (EPC) Band C by 2030, Environmental Risk Factors, Every Mind Matters Campaign (Mental Health Awareness), Every Mind Matters Campaign (PHE), Female Healthy Life Expectancy, From Life Span to Health Span, Future of Work, Genetics, Genomic Medicine Service in the NHS, Genomics and Personalised Medicine, Genomics and Theraputics, Genomics England, Grassroots Football, Green Spaces and Clean Air, Harwell Research Campus (Oxford), Health As a Shared Responsibility, Health Inequalities, Health Inequalities in England, Health is Everyone’s Business, Healthier You, Healthier You: NHS Diabetes Prevention Programme, Healthy Ageing, Healthy Child Programme, Healthy Life Expectancy, Healthy Living Pharmacies (HLPs), Healthy New Towns, Healthy Places, Healthy Sleeping, Home of 2030 Design Competition, Homes and Neighbourhoods, HomeShare, Hungry Little Minds, Improving Lives: Work Health and Disability Green Paper, Improving Population Health, Improving Public Health, Improving the Lives of Families Affected by Alcohol, Information Technology, Innovation Infrastructure, Innovation Technology and Infrastructure, Integrated Care Systems (ICSs), Intelligent Health Checks, Investment in Information Technology, IT Infrastructure, Ivacaftor, Kaftrio, Leeds, Leicester’s Healthy Teeth Happy Smiles, Life Expectancy, Life-Course Approach to Healthy and Active Ageing, Lifestyle Risk Factors, Living Healthier for Longer, London, Long Term Plan (LTP), Lumacaftor, Matthew Taylor Review of Modern Working Practices, Medical Research Council (MRC), Mental Health Problems, Mental Illness Prevention, Middlesbrough Staying Put Home Improvement Agency, Modifiable Risk Factors, National Artificial Intelligence Laboratory (NHS England), National Childhood Obesity Strategy, National Genomics Healthcare Strategy, National Guidance on Daily Recommended Hours of Sleep for Different Age Groups, National Moving Healthcare Professionals Partnership Programme (PHE and Sport England), National Prevention Concordat for Better Mental Health (PHE), Neurological Disorders, NHS Community Pharmacy Contractual Framework (CPCF), NHS Diagnostic Services, NHS England’s Healthy New Towns Programme, NHS Health Check, NHS Health Checks Programme, Nicola Blackwood: Minister for Public Health and Innovation, Nucleic Acid Therapy Accelerator (NATA), Nutritional and Metabolic Disorders, Orkambi, Our Dorset: Prevention in an Integrated Care System, Oxford, Parkinson's Disease: Smartwatch Trackers, Personal Kinetigraphs (PKG), Personalised Health, Personalised Medicine, Personalised Prevention, Personalised Protection Against Future Ill Health, Physical Activity, Plymouth University, Polygenic Risk Scores (PRS), Population Health, Precision Medicine, Predictive Prevention, Preventable Ill Health, Preventable Illness, Prevention Agenda, Prevention Better Than Cure, Prevention Concordat (PHE), Prevention Concordat for Better Mental Health for All, Prevention Concordat Programme for Better Mental Health, Professor Sir Mark Walport, Professor Sir Mike Richards: Former Chief Inspector of Hospitals (CQC), Professor Sir Mike Richards: Review of Cancer Screening, Public Health, Putting Health into Place, Recovery Champion for England, Reducing Parental Conflict Programme, Risk Factors, Rosalind Franklin Research Institute, Rt Hon Andrea Leadsom MP, Rt Hon Matt Hancock MP, Safer Communities, Screening, Screening Technology, Seema Kennedy: Parliamentary Under Secretary of State for Public Health and Primary Care, Self-Care, Shared Lives and Homeshare Networks, Shared Lives Plus, Shared Responsibility, Sir Mark Walport: Chief Executive of UK Research and Innovation (UKRI), Sleep Deprivation, Sleep Hygiene, Sleeping Well, Smartwatch Trackers. BBC Health News, Smoke-Free 2030 Ambition, Smoking Cessation, Social Determinants of Health, Social Determinants of Health Inequalities, Social Gradient in Healthy Life Expectancy, Social Gradient in Life Expectancy, Social Prescribing, Social Prescribing Academy, Societal Determinants of Health, Socio-Environmental Risk Factors, Southwark Digital Health Check Tool, Staying Put, Stevenson / Farmer Review of Mental Health and Employers (Thriving at Work), Strategic Priorities Fund (SPF), Supporting Self-Care, Symkevi, Tackling Causes of Preventable Ill Health, Tackling Multimorbidity at Scale, Tackling Multimorbidity at Scale: Unpicking Disease Clustering Biological Pathways and Trajectories, Tailored (“Personalised”) Lifestyle Advice, Targeted (“Personalised”) Support, Tezacaftor, Thrive Bristol, Thriving at Work: the Stevenson / Farmer Review of Mental Health and Employers, Tobacco Cessation, Tobacco Consumption, Transformational Technologies, Transformative Health Technology, Transformative Technology, Transforming Children and Young People's Mental Health Provision, UK Biobank, UK Centre of Evidence Implementation in Adult Social Care, UK Centre of Evidence Implementation in Adult Social Care (ESRC), UK National Screening Committee (UK NSC), UK Research and Innovation (UKRI), Value for Money, Versus Arthritis, Vertex Pharmaceuticals, West Midlands Violence Prevention Alliance, Whole Genome Sequencing (WGS), Wider Determinants of Health, Wider Determinants of Mental Health, Wigan Deal: Adult Social Care and Wellbeing, World-Class Research | Leave a comment

Tag Archives: Accelerating Detection of Disease (ADD) Challenge

Recent Posts

Archives

Categories

Google Translate (100+ Languages)

Recommended Sites